跳至主要内容
临床试验/NL-OMON48161
NL-OMON48161招募中不适用

The application of induced pluripotent stem cells to predict return of the same kidney disease after transplantation. - A cross-match to predict FSGS recurrence after kidney transplantation.

Radboud Universitair Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Population:
  • 1. Adult patients (18 years or older) with diagnosis of FSGS in the native kidneys, and known outcome after kidney transplantation (recurrent FSGS or non-recurrent FSGS).
  • 2. Living persons who have previously donated a kidney to patients specified under 1.;Inclusion criteria
  • 1. Established outcome after kidney transplantation (recurrence or non-recurrence of FSGS);
  • 2. Living kidney donation;
  • 3. Donor available for participation in the study

排除标准

  • 1. Follow-up after transplantation too short to rule out development of late FSGS recurrence (less than one year);
  • 2. Unknown histological diagnosis in the native kidney;
  • 3. No communication between patient and donor.

研究者

相似试验

尚未招募
不适用
self-replicating (Pluripotent stem) cells evaluation in patients of hepatocellular cancer
CTRI/2019/11/022000Tata Memorial Hospital
尚未招募
不适用
Combined use of induced pluripotent stem cell derived cardiomyocytes and 3D-heart tissue to develop Therapies for pediatric heart failure in Tetratology of Fallot.pulmonary atresia with ventricular septal defectTetralogy of Fallot10010394
NL-OMON51398Erasmus MC, Universitair Medisch Centrum Rotterdam5
已完成
不适用
Development of induced pluripotent stem (iPS) cells from patients with muscular disorders for the study of the pathogenesis of the diseases and development of therapiesSkeletal muscle disease Myotonic dystrophy Muscular dystrophies
JPRN-UMIN000008958Osaka University Graduate School of Medicine20
招募中
不适用
Generation of induced pluripotent stem cells (iPSCs) derived from intractable retinal disease patients and clarification of the diseases and novel therapies development by using retinal tissues differentiated and induced from iPSC.Intractable retinal diseases
JPRN-UMIN000021556aboretory for Retinal Regeneration Riken Center for Developmental Biology20
Enrolling By Invitation
不适用
Induced pluripotent stem cell (iPSC)-derived immortalized megakaryocyte cell lines (imMKCLs) from voluntary blood component donors with specific HLA haplotypes towards platelet products in transfusion therapy.Thrombocytopenia
JPRN-UMIN000015345?Center for iPS Cell Research and Application (CiRA), Kyoto University?Kyoto University Hospital3